Invention Grant
- Patent Title: Therapies for obesity, diabetes and related indications
-
Application No.: US15723755Application Date: 2017-10-03
-
Publication No.: US10660939B2Publication Date: 2020-05-26
- Inventor: Carl Spana , John H. Dodd , Marie Makhlina
- Applicant: Palatin Technologies, Inc.
- Applicant Address: US NJ Cranbury
- Assignee: Palatin Technologies, Inc.
- Current Assignee: Palatin Technologies, Inc.
- Current Assignee Address: US NJ Cranbury
- Agent Stephen A. Slusher
- Main IPC: A61K38/26
- IPC: A61K38/26 ; A61K38/12 ; A61K9/00 ; A61P3/00 ; A61P3/04 ; A61P3/10
Abstract:
The invention relates to methods, uses, compositions and formulations including a melanocortin receptor-4 agonist and a glucagon-like peptide-1 receptor agonist for treatment of obesity, diabetes, metabolic syndrome and related indications, diseases or disorders.
Public/Granted literature
- US20180153965A1 Therapies for Obesity, Diabetes and Related Indications Public/Granted day:2018-06-07
Information query
IPC分类:
